Article Versions Notes

Bernardi S, Farina M, Bosio K, Di Lucanardo A, Leoni A, Re F, Polverelli N, Turra A, Morello E, Accorsi Buttini E, et al. Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection. Cancers. 2022; 14(18):4504. https://doi.org/10.3390/cancers14184504

Bernardi, Simona, Mirko Farina, Katia Bosio, Anna Di Lucanardo, Alessandro Leoni, Federica Re, Nicola Polverelli, Alessandro Turra, Enrico Morello, Eugenia Accorsi Buttini, and et al. 2022. "Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection" Cancers 14, no. 18: 4504. https://doi.org/10.3390/cancers14184504

Bernardi, S., Farina, M., Bosio, K., Di Lucanardo, A., Leoni, A., Re, F., Polverelli, N., Turra, A., Morello, E., Accorsi Buttini, E., Zollner, T., Bonvicini, C., Malagola, M., & Russo, D. (2022). Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection. Cancers, 14(18), 4504. https://doi.org/10.3390/cancers14184504